ArcticZymes Technologies ASA (OSL: AZT)

Market Cap	712.96M
Revenue (ttm)	110.76M
Net Income (ttm)	4.63M
Shares Out	51.07M
EPS (ttm)	0.08
PE Ratio	164.61
Forward PE	109.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,139
Average Volume	60,196
Open	14.60
Previous Close	14.16
Day's Range	14.00 - 14.60
52-Week Range	12.34 - 41.85
Beta	1.00
RSI	51.32
Earnings Date	Feb 13, 2025

About OSL: AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during man...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 61
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2023, AZT's revenue was 119.65 million, a decrease of -13.09% compared to the previous year's 137.67 million. Earnings were 19.43 million, a decrease of -40.89%.